Potential survival benefit for patients receiving allogeneic hematopoietic stem cell transplantation after nivolumab therapy for relapse/refractory Hodgkin lymphoma: Real-life experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO).
暂无分享，去创建一个
C. Martínez | J. Bargay | R. García-Sanz | L. Palomera | E. Domingo-Domènech | C. Carpio | S. Romero | A. Gutiérrez | I. Heras | M. de Haro | I. García-García | E. Ríos-Herranz | J. Buch | I. Zeberio | Antonia Rodriguez-Izquierdo | R. Alonso | C. Barrenetxea | M. D. de Haro | A. Rodriguez-Izquierdo | Rosalía Alonso